Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER VACCINES

A prophylactic and a therapeutic against AML

Nature Biomedical Engineering volume 4, pages 4–5 (2020)Cite this article

Subjects

An injectable biomaterial vaccine encapsulating antigens associated with acute myeloid leukaemia, dendritic-cell-targeting pro-inflammatory cytokines and an adjuvant protects mice from the disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Subcutaneous administration of a macroporous biomaterial vaccine for robust and durable tumour-specific immune responses against AML.

References

  1. Döhner, H. et al. N. Engl. J. Med. 373, 1136–1152 (2015).

    Article  Google Scholar 

  2. Estey, E. et al. Lancet 368, 1894–1907 (2006).

    Article  Google Scholar 

  3. Podoltsev, N. et al. Blood Rev. 31, 43–62 (2017).

    Article  Google Scholar 

  4. Grosso, D. et al. Cancer 121, 2689–2704 (2015).

    Article  CAS  Google Scholar 

  5. Anguille, S. et al. Leukemia 26, 2186–2196 (2012).

    Article  CAS  Google Scholar 

  6. Shi, Y. et al. Blood Adv. 2, 3177–3192 (2018).

    Article  CAS  Google Scholar 

  7. Shah, N. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-019-0503-3 (2020).

    Article  Google Scholar 

  8. Ali, O. et al. Sci. Transl. Med. 1, 8ra19 (2009).

    Article  Google Scholar 

  9. Galluzzi, L. et al. Cancer Cell 28, 690–714 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA

    Guojun Chen & Zhen Gu

  2. Jonsson Comprehensive Cancer Center, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA

    Zhen Gu

Authors
  1. Guojun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhen Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhen Gu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, G., Gu, Z. A prophylactic and a therapeutic against AML. Nat Biomed Eng 4, 4–5 (2020). https://doi.org/10.1038/s41551-019-0509-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-019-0509-x

Search

Advanced search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology